SG Americas Securities
IMUX icon

SG Americas Securities’s Immunic IMUX Stock Holding History

SG Americas Securities’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,441
Closed -$128K – 3584
2021
Q3 		$128K Buy
+1,441
New +$142K ﹤0.01% 3542
2019
Q2 		– Sell
-652
Closed -$51K – 3249
2019
Q1 		$51K Buy
652
+153
+31% +$13.4K ﹤0.01% 3187
2018
Q4 		$37K Buy
+499
New +$58.4K ﹤0.01% 2861
2017
Q2 		– Sell
-104
Closed -$167K – 3341
2017
Q1 		$167K Buy
+104
New +$190K ﹤0.01% 2569
2016
Q3 		– Sell
-31
Closed -$76K – 3423
2016
Q2 		$76K Buy
+31
New +$102K ﹤0.01% 2426

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SG Americas Securities's IMUX Position: Q4 2021 in Review

SG Americas Securities sold out of Immunic (IMUX) in Q4 2021, closing a stake of 1,441 shares — an estimated $128K sold.

SG Americas Securities first reported a position in IMUX in Q2 2016 and held it in 5 quarters. The position peaked at $167K in Q1 2017. 67 funds tracked by Wall St. Rank hold IMUX as of Q4 2021.

  • SG Americas Securities reported no remaining Immunic position as of Q4 2021 after selling out during the quarter.
  • SG Americas Securities sold 1,441 Immunic shares in Q4 2021, an estimated $128K.
  • SG Americas Securities first reported a position in Immunic in Q2 2016 and held it in 5 quarters.
  • SG Americas Securities's Immunic position peaked at $167K in Q1 2017.
  • 67 funds tracked by Wall St. Rank held Immunic as of Q4 2021.

Based on SG Americas Securities's 13F filing for Q4 2021, filed 7 Feb 2022.